Amicogen Inc operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Amicogen Inc with three other
companies in this sector in South Korea:
Caregen Co Ltd
sales of 57.89 billion Korean Won [US$51.29 million]
of which 100%
was Manufacture & Sale of Chemicals),
High Tech Pharm Company., Limited
(66.05 billion Korean Won [US$58.52 million]
Yuyu Pharma Incorporated
(83.78 billion Korean Won [US$74.23 million]
Amicogen Inc reported sales of 73.67 billion Korean Won (US$65.27 million)
December of 2017.
increase of 6.8%
versus 2016, when the company's sales were 68.97 billion Korean Won.
Sales at Amicogen Inc have increased during each of the previous five years
(and since 2012, sales have increased a total of 352%).